IMITREX 6 mg/.5mL
sumatriptan · INJECTION · GlaxoSmithKline LLC
No Recall HistoryCurrently in Shortage
Plain English
IMITREX is a injection containing sumatriptan at 6 mg/.5mL, taken subcutaneous. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- IMITREX
- Generic Name
- sumatriptan
- NDC Code (Product)
0173-0479- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 6 mg/.5mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA020080
- Marketing Start
- 01/23/1997
Recall History
No Recall HistoryFrequently Asked Questions
What is IMITREX used for?
IMITREX contains sumatriptan. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is IMITREX a controlled substance?
IMITREX is not classified as a controlled substance by the DEA.
What is the generic name for IMITREX?
The generic name for IMITREX is sumatriptan. There are 11 other brand versions of sumatriptan.
What is the NDC code for IMITREX 6 mg/.5mL?
The NDC (National Drug Code) for IMITREX 6 mg/.5mL is 0173-0479, listed by GlaxoSmithKline LLC.
Other Sumatriptan Brands
See all →- sumatriptan6 mg/.5mL83270-151
- Sumatriptan25 mg/185766-093
- Onzetra Xsail11 mg/142847-311
- Sumatriptan100 mg/150090-1130
- Sumatriptan100 mg/155700-899
- Sumatriptan Succinate50 mg/163187-049
- SUMATRIPTAN100 mg/163187-323
- SUMATRIPTAN5 mg/100uL66993-081
- Sumatriptan50 mg/168071-3802
- Sumatriptan Succinate25 mg/10378-5630
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)